BackVivos Therapeutics Overview

Vivos Therapeutics Cost of Revenue

Cost of Revenue analysis for VVOS.

Quarterly Cost of Revenue

$2.08M
↑ 38.16% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$7.47M
↑ 23.77% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin